BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

PHC Corporation Debuts LiCellGrow Prototype for Enhanced Cell & Gene Therapy Production

-PHC Corporation Biomedical Division (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura, hereinafter referred to as the "Biomedical Divisio...

September 03, 2024 | News

Inside Asia-Pacific’s Cell and Gene Therapy Evolution: A Conversation with Raymond Chow, VP of Commercial, APAC at Cytiva

In an interaction with BioPharma APAC, Raymond Chow, Vice President of Commercial for Asia-Pacific at Cytiva, shares his insights on the rapidly evolving l...

September 02, 2024 | Interaction

GenScript’s Legend Biotech Secures NMPA Approval for Pioneering Cilta-cel Therapy in China

Legend Biotech (NASDAQ: LEGN), a subsidiary of GenScript Biotech Corporation (hereinafter referred to as "GenScript"), a global leader in life sciences res...

August 28, 2024 | News

CARsgen Therapeutics Completes Enrollment in Pivotal Phase II Trial of Satri-Cel for Advanced Gastric Cancer in China

CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors...

August 20, 2024 | News

Lonza’s MODA-ES® Platform Transforms Cell and Gene Therapy Manufacturing at Champalimaud Foundation

MODA-ES® Platform, a next-generation manufacturing execution system for cell and gene therapies, facilitates a cost-effective tra...

August 14, 2024 | News

Biosyngen’s EBV-Specific CAR-T Therapy, BRG01, Secures FDA Approval for Pivotal Phase II Trial in U.S.

Biosyngen is proud to announce that the U.S. Food and Drug Administration (FDA) has approved its BRG01, an EBV-specific CAR-T cell therapy, to proceed with...

August 13, 2024 | News

WuXi Biologics and Medigene Forge Strategic Partnership to Advance TCR-Guided T Cell Engagers for Cancer Treatment

Partnership leverages Medigene's leadership for T cell receptor (TCR) generation and characterization and WuXi Biologics' unique anti-CD3 mAb, its T cell...

August 09, 2024 | News

Andelyn Biosciences Partners with Broad Institute to Enhance Gene Therapy Platform with MyoAAV Plasmids

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has entere...

August 07, 2024 | News

Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as Diagnostic Tool for Synovial Sarcoma Treatment

Agilent announced that it has received FDA approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid in identifying patients with...

August 05, 2024 | News

Porton Advanced and Geneseed Biotech Forge Strategic Partnership to Accelerate circRNA Therapies

Porton Advanced Solutions ("Porton Advanced") announced that it had reached a strategic cooperation with Guangzhou Geneseed Biotech Co., Ltd ("Geneseed Bio...

July 31, 2024 | News

IASO Bio Receives Second FDA IND Approval in 2024 for Groundbreaking Cell Therapy Eque-cel to Treat Multiple Sclerosis

IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therap...

July 25, 2024 | News

DiscGenics Receives FDA Approval to Proceed with Phase III Clinical Trials for Regenerative Cell Therapy for Lumbar Degenerative Disc Disease

DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoske...

July 23, 2024 | News

Agilent Technologies Launches ProteoAnalyzer System at SCGT Summit

Agilent Technologies Inc. announced the release of its new ProteoAnalyzer system, in addition to existing product updates at the Singapore Cell and Ge...

July 22, 2024 | News

ACROBiosystems Launches Resilient Supply Brand to Boost Cell and Gene Therapy Development at ISSCR Annual Meeting

At the recent International Society for Stem Cell Research (ISSCR) Annual Meeting in Hamburg, ACROBiosystems announced its new GMP-centered brand, Res...

July 19, 2024 | News

Stay Connected